National Cancer Institute

Rockville, Maryland 20850

1 studies enrolling now · 5 studies all time

What they study most

CFC Syndrome (CFCS), Chordoma, Congenital Bone Marrow Failure Syndromes, Costello Syndrome, Fallopian Tube Carcinoma, Fanconi Anemia, Hematopoietic and Lymphoid Cell Neoplasm, Legius Syndrome, Li-Fraumeni Syndrome, Malignant Solid Neoplasm, Melanoma, Neurofibromatosis Type 1

Studies at this site

• Clinical Genetics Branch Eligibility Screening Survey — Starting soon
• Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer — Running, not enrolling
• Tocilizumab for Patients With Cancer and COVID-19 Disease — Stopped early
• Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors — Completed
• Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) — Completed